Cargando…
Forecasting drug utilization and expenditure in a metropolitan health region
BACKGROUND: New pharmacological therapies are challenging the healthcare systems, and there is an increasing need to assess their therapeutic value in relation to existing alternatives as well as their potential budget impact. Consequently, new models to introduce drugs in healthcare are urgently ne...
Autores principales: | Wettermark, Björn, Persson, Marie E, Wilking, Nils, Kalin, Mats, Korkmaz, Seher, Hjemdahl, Paul, Godman, Brian, Petzold, Max, Gustafsson, Lars L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893175/ https://www.ncbi.nlm.nih.gov/pubmed/20478043 http://dx.doi.org/10.1186/1472-6963-10-128 |
Ejemplares similares
-
Forecasting drug utilization and expenditure: ten years of experience in Stockholm
por: Linnér, Love, et al.
Publicado: (2020) -
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017) -
Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care
por: Forslund, Tomas, et al.
Publicado: (2011) -
Time trends in statin utilisation and coronary mortality in Western European countries
por: Vancheri, Federico, et al.
Publicado: (2016) -
EU pharmaceutical expenditure forecast
por: Urbinati, Duccio, et al.
Publicado: (2014)